Tuberculosis is still a major health problem in most developing countdes and its incidence is rising in many developed countries. This resurgence has been attributed to the HIV epidemic and TB has been declared as a global health emergency by WHO in 1993. The diagnosis of tuberculosis mainly depends upon initial clinical suspicion and radiographic findings with subsequent bacteriological confirmation by sputum smear examination and culture. Lack of sensitivity in smear examination, non specificity of radiological findings, extended turn around time of Mycobactedum tuberculosis culture and difficulties in diagnosing paucibacillary, childhood and extrapulmonary tuberculosis has necessitated to explore the utility of immunodiagnosis of tuberculosis as a convenient and cost effective test to supplement clinical information for definite diagnosis. Many commercial tests are available in the market for diagnosis of TB. Most of these tests are based on the detection of IgG, IgA and IgM antibodies to specific mycobacterial antigen or mixture of antigens. Indigenous immunoassay systems have explored excretory-secretory ES-31 mycobactedal antigen for immunodiagnosis of'lB. Many a time there is lack of consistent elevation in all the three Ig classes in active infection thus making it more important to determine the ideal antibody isotype assay for reliable diagnosis of tuberculosis and to save the costs of the patient for unnecessary investigations.
Due to problem in early and unequivocal detection and failure of control programmes for vanous reasons the TB problem will continue to evade solution.
DIAGNOSIS OF TUBERCULOSIS
Ever since the discovery of Kochs Bacillus, the diagnosis of tuberculosis still largely depends upon the clinical examination, radiographic findings with subsequent laboratory confirmation by bacteriological examination. Smear examination and in vitro culture of tubercle bacilli has remained the gold standard. But the sensitivity of AFB smear is compromised because greater than 104 bacilli per ml of sputum are required for reliable detection. Though sputum examination is supposed to have 75% sensitivity and 98% specificity but in practice, the sensitivity has been observed to be around 30% for a number of reasons (2) . The failure rate being substantially greater in children because they rarely produce sputum specimen adequate for bacteriological examination. The in vitro culture methods require an extended turn around time. The Various studies which have measured the levels of different antibodies against these antigens are briefly reviewed here.
A60 ANTIGEN
The A 60 antigen used in ERBA LISA kit is a thermostable component of PPD and has been used in the serodiagnosis of TB. Unfortunately this molecule is not specific for mycobacteria, because it is also present in the Nocordia and Corney bacterium species. In a large study conducted (5) The 38 kDa antigen was originally der~cdbed as a component of antigen 5 (9). Since then it has been proved to be specific (9,10,11,12) but the sensitivity of the test even with the addition of 16-kDa antigen was low. Detection of IgG against 38 kDa antigen has revealed a sensitivity of 64% and specificity of 81% (13, 14) . The evaluation of Pathozyme TB complex and pathozyme myco was undertaken along with other serological tests for detection of IgG, IgA and IgM antibodies. Combining IgA or IgM as an adjunct test increased the sensitivity but at the cost of specificity (15) . In comparative analytical study using 5 different commercial tests (16) (Pathozyme TB complex, Pathozyme Myco, Detect TB, Tuberculosis IgG ELISA and Myco Dot) to evaluate the use of mycobactedal antibody detection in an endemic area, the sensitivity of individual kits varied from 46% to 68%. In serodiagnosis of EPTB, using 38 kDa for IgG antibody detection, it was found to be 73% sensitive and 98% specific (17) . Antibody IgG titres were also found to be related to the extent of the disease.
SEVA TB ES-31 ANTIGEN
In an elegant study (18) In most of the studies, it has been seen that Immunoglobulin G holds the great promise in diagnosing an active disease in both children as well as adults, as compared to IgM or IgA class. IgG is also found to be an useful antibody for monitoring the response of antitubercular treatment. In a cross sectional study (20) , on changes in IgG, IgA and IgM levels along with other serum proteins in Pulmonary TB during therapy, serum IgG and IgA levels have mostly reported to be increased while most of the authors have reported unchanged IgM levels. IgG has been found to be mu(;h higher (p<0.001) at 0 month compared to control population 3 while no significant difference was found in IgA class. IgM levels at 0 month were also higher when compared to control groups. In general IgG levels have been found to be increased in active TB (21-27), increased IgM levels have also been reported to be in two studies (22, 25) while several studies revealed no significant change (21, 23, 24, 26) . IgA levels have also been reported to be increased in several studies (21, 23, 24, 25, 27 ) but more or less in extensive, advanced diseases which are unlikely to be missed on clinical examination. Measurement of different classes of immunoglobulins using different antigenic preparations have shown that IgM antibody levels have been found to be so low that their reliable measurement has been difficult. IgA levels have generally paralleled IgG class, but also have tended to be low and more difficult to measure reliably. IgM is found to be the initial antibody produced. This feature suggests that the presence of IgM antibody to TB protein antigen m!ght be characteristic of early disease, which may not hold much diagnostic promise because of the delay on the part of the patients in visiting qualified doctors.
It is also high time for the practising clinician to rethink on the unnecessary financial burden put on poor patients by long list of diagnostic tests. Regarding low cost and relative simplicity of the technique, ELISAwill be a boon for the poor patients. At present, considering the delay of patients in getting consultatioq from qualified person, we have to decide whether it is useful to go for all the classes of immunoglobulins against mycobacterial antigens? As various studies have revealed, it will be better to go only for 'lgG' estimation assay as an adjunct test for confirming clinical suspicion. Assay of IgM and IgA will not be of much help in eliciting any more information. Further in tuberculosis cases negative for IgG antibody, antigen detection may be more useful as observed with 31 kDa antigen (19) in confirming active tuberculosis infection.
